Literature DB >> 1174820

Collagen biosynthesis in normal and hypertrophic scars and keloid as a function of the duration of the scar.

R D Craig, J D Schofield, D S Jackson.   

Abstract

The rates of collagen biosynthesis and the tissue concentrations of collagen in normal scar, hypertrophic scar and keloid were determined as a function of the duration of the lesions. The rate of collagen synthesis in normal scar was approximately constant between 6 months and 20 years after the initial wounding, but in both hypertrophic scar and keloid the rate was initially approximately twice that in normal scar, and 2-3 years after wounding it fell to approximately the same level as in normal scar. The tissue concentration of collagen appeared to be relatively constant in normal scar with respect to the time elapsed after wounding, but in both types of abnormal scar it was initially somewhat lower than normal scar and then rose to values higher than in normal scar after about 2-3 years. Since similar results were obtained for both types of abnormal scar in terms of the rates of collagen biosynthesis with respect to the time elapsed after wounding and also in terms of the tissue concentrations of collagen, this may indicate that the events in the pathogenesis of both abnormal scar types are similar. The results also raise the possibility that the formation of both types of abnormal scar may occur in two phases: an initial phase characterized by abnormally high rates of collagen biosynthesis and a later phase characterized by essentially normal rates of collagen biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174820     DOI: 10.1002/bjs.1800620917

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

Review 1.  A primary care perspective on keloids.

Authors:  Steven Davidson; Nasir Aziz; Rashid M Rashid; Amor Khachemoune
Journal:  Medscape J Med       Date:  2009-01-20

2.  Intramuscular hypertrophic scar: an unusual complication following soft tissue sarcoma resection.

Authors:  J X O'Connell; J C English; C P Beauchamp; D G Connell
Journal:  Skeletal Radiol       Date:  1995-05       Impact factor: 2.199

3.  MMP- and TIMP-secretion by human cutaneous keratinocytes and fibroblasts--impact of coculture and hydration.

Authors:  Andrea A Tandara; Thomas A Mustoe
Journal:  J Plast Reconstr Aesthet Surg       Date:  2010-06-09       Impact factor: 2.740

4.  Collagen polymorphism in pathologic human scars.

Authors:  L Weber; W N Meigel; W Spier
Journal:  Arch Dermatol Res       Date:  1978-02-15       Impact factor: 3.017

5.  Keloids and hypertrophic scars: characteristic vascular structures visualized by using dermoscopy.

Authors:  Min Gun Yoo; Il-Hwan Kim
Journal:  Ann Dermatol       Date:  2014-09-26       Impact factor: 1.444

6.  Type 1 procollagen as a marker of severity of scarring after sternotomy: effects of topical corticosteroids.

Authors:  Y Riaz; H T Cook; A Wangoo; B Glenville; R J Shaw
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

7.  Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens.

Authors:  Gisele V Oliveira; Hal K Hawkins; David Chinkes; Ann Burke; Andre Luiz Pasqua Tavares; Marcia Ramos-e-Silva; Thomas B Albrecht; Gregory T Kitten; David N Herndon
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

Review 8.  Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Exp Dermatol       Date:  2020-07-06       Impact factor: 3.960

9.  Predictive Factors of Keloid Formation in Congenital Foot Syndactyly.

Authors:  Sang Ho Oh; Sang Hyun Woo
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-11-29

10.  Early cessation of pressure garment therapy results in scar contraction and thickening.

Authors:  Danielle M DeBruler; Jacob C Zbinden; Molly E Baumann; Britani N Blackstone; Megan M Malara; J Kevin Bailey; Dorothy M Supp; Heather M Powell
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.